potential indications for glp-1 receptor agonists keep expanding and Diabetic Kidney Disease: A Call of Attention to Nephrologists Current Insights, Advantages and Challenges
Description
[DOI] [PubMed] [Google Scholar] 6.Dervenis C, Johnson CD, Bassi C, et al

(3) Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets the TITRATETM study [PubMed Abstract] [Full Text HTML] [Full Text PDF]

J Am Stat Assoc (1989) 84(408):10748

And the first GLP-1 agonist for obesity/weight loss was approved a full decade ago

evaluated the molecular mechanisms through which semaglutide mediated resolution of MASH [17]
Yammine is optimistic, particularly for people who are addicted to several substances: A substantial proportion of people with SUD uses multiple substances
